
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
Latest quote
$3.5498
−$0.1652 · -4.45%
Tilray Brands, Inc. is a diversified global consumer packaged goods company primarily involved in the cultivation, processing, marketing, and sale of cannabis products. Its operations span a significant international footprint, encompassing Canada, the United States, Europe, Australia, New Zealand, and Latin America. The company organizes its business across four distinct divisions: Cannabis, Distribution, Beverage Alcohol, and Wellness. Within its cannabis division, Tilray provides a comprehensive range of medical and adult-use items, including regulated products like GMP-certified cannabis flowers, oils, vaporizers, edibles, and topical applications. Beyond cannabis, Tilray's portfolio extends to the procurement and resale of pharmaceutical and wellness goods. Furthermore, it manufactures, promotes, and distributes a variety of alcoholic beverages, alongside hemp-derived food and other wellness items. The company markets its diverse offerings under numerous recognized brands, such as Tilray, Aphria, SweetWater, and Breckenridge Distillery. Its products reach a wide array of customers, including retail outlets, wholesale partners, medical patients, healthcare practitioners, hospitals, pharmacies, scientific researchers, governmental bodies, and directly to end consumers. Formerly operating as Tilray, Inc., the corporation is headquartered in Leamington, Canada.
Regular session
$3.5498
−$0.1652 · -4.45%
Regular session · ET · Market data may be delayed.
Tilray Brands, Inc. is a diversified global consumer packaged goods company primarily involved in the cultivation, processing, marketing, and sale of cannabis products. Its operations span a significant international footprint, encompassing Canada, the United States, Europe, Australia, New Zealand, and Latin America. The company organizes its business across four distinct divisions: Cannabis, Distribution, Beverage Alcohol, and Wellness. Within its cannabis division, Tilray provides a comprehensive range of medical and adult-use items, including regulated products like GMP-certified cannabis flowers, oils, vaporizers, edibles, and topical applications. Beyond cannabis, Tilray's portfolio extends to the procurement and resale of pharmaceutical and wellness goods. Furthermore, it manufactures, promotes, and distributes a variety of alcoholic beverages, alongside hemp-derived food and other wellness items. The company markets its diverse offerings under numerous recognized brands, such as Tilray, Aphria, SweetWater, and Breckenridge Distillery. Its products reach a wide array of customers, including retail outlets, wholesale partners, medical patients, healthcare practitioners, hospitals, pharmacies, scientific researchers, governmental bodies, and directly to end consumers. Formerly operating as Tilray, Inc., the corporation is headquartered in Leamington, Canada.
Day range
Current $3.5498
52-week range
Current $3.5498
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
62
Undervalued
Sentiment
33
Bearish
Risk
64
High Risk
Momentum
20
Strong Down
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Tilray Brands, Inc. is a diversified global consumer packaged goods company primarily involved in the cultivation, processing, marketing, and sale of cannabis products. Its operations span a significant international footprint, encompassing Canada, the United States, Europe, Australia, New Zealand, and Latin America. The company organizes its business across four distinct divisions: Cannabis, Distribution, Beverage Alcohol, and Wellness. Within its cannabis division, Tilray provides a comprehensive range of medical and adult-use items, including regulated products like GMP-certified cannabis flowers, oils, vaporizers, edibles, and topical applications. Beyond cannabis, Tilray's portfolio extends to the procurement and resale of pharmaceutical and wellness goods. Furthermore, it manufactures, promotes, and distributes a variety of alcoholic beverages, alongside hemp-derived food and other wellness items. The company markets its diverse offerings under numerous recognized brands, such as Tilray, Aphria, SweetWater, and Breckenridge Distillery. Its products reach a wide array of customers, including retail outlets, wholesale partners, medical patients, healthcare practitioners, hospitals, pharmacies, scientific researchers, governmental bodies, and directly to end consumers. Formerly operating as Tilray, Inc., the corporation is headquartered in Leamington, Canada.
Day range
Current $3.5498
52-week range
Current $3.5498
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 915.45M USD | 1.13B USD | 1.07B USD | 844.72M USD | 628.37M USD |
| Cost of goods sold | 655.01M USD | 796.88M USD | 770.66M USD | 646.77M USD | 511.56M USD |
| Gross profit | 260.44M USD | 330.11M USD | 304.33M USD | 197.95M USD | 116.82M USD |
| Research and development | 361K USD | 389.7K USD | 865.23K USD | 918.64K USD | 1.52M USD |
| Selling, general, and administrative | 295.25M USD | 356.06M USD | 341.63M USD | 311.13M USD | 233.38M USD |
| Operating expenses | 323.47M USD | 3.46B USD | 542.43M USD | 2.04B USD | 350.08M USD |
| Interest income | 6.25M USD | 15.61M USD | 17.48M USD | 44.48M USD | 11.74M USD |
| Interest expense | 29.91M USD | 56.71M USD | 67.13M USD | 62.79M USD | 39.68M USD |
| Depreciation and amortization | 67.6M USD | 183.17M USD | 172.93M USD | 175.31M USD | 154.59M USD |
| Operating income | −63.03M USD | −3.13B USD | −238.1M USD | −1.84B USD | −233.27M USD |
| Net income | −122.57M USD | −3B USD | −333.8M USD | −1.96B USD | −476.8M USD |
Company facts updated Oct 8, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$65.01
1731.37% upside| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Dec 2, 2025 | 1:10 | — | — |
Stock split | May 3, 2021 | 8,381:10,000 | — | — |
Effective Dec 2, 2025
1:10
Effective May 3, 2021
8,381:10,000
Funds reporting this stock among their holdings, ordered by reported position size.
Amplify Alternative Harvest ETFMJ10.42M9.80%106.33M USD1.12%$23.94-1.76%
Vanguard Health Care ETFVHT1.73M0.01%22B USD0.09%$309.38-1.88%
AdvisorShares Pure Cannabis ETFYOLO405.83K1.23%32.94M USD0.91%$2.8264+2.22%
iShares U.S. Small-Cap Equity Factor ETFSMLF382.38K0.01%4.16B USD0.15%$83.935-0.82%
Dimensional - International Small Cap ETFDFIS295.2K0.01%5.74B USD0.39%$35.495-0.91%
Dimensional - International Core Equity Market ETFDFAI270.31K0.00%17.78B USD0.18%$40.85-0.73%
Fidelity MSCI Health Care Index ETFFHLC230.28K0.01%3.54B USD0.08%$79.94-1.84%
Dimensional - International Core Equity 2 ETFDFIC130.02K0.00%15.01B USD0.22%$37.105-0.63%
Amplify Alternative Harvest ETFMJ
Vanguard Health Care ETFVHT
AdvisorShares Pure Cannabis ETFYOLO
iShares U.S. Small-Cap Equity Factor ETFSMLF
Dimensional - International Small Cap ETFDFIS
Dimensional - International Core Equity Market ETFDFAI
Fidelity MSCI Health Care Index ETFFHLC
Dimensional - International Core Equity 2 ETFDFICAI-generated and delayed market data for informational and educational purposes only. Not investment advice.